- Cartilage regeneration, involving biological repair or replacement of damaged cartilage tissues, is becoming a key focus in orthopedic and sports medicine due to its potential to restore mobility, relieve pain, and delay or eliminate the need for joint replacement surgeries
- The growing demand for cartilage regeneration procedures is primarily driven by the rising incidence of osteoarthritis, sports injuries, and obesity-related joint disorders, along with increasing awareness of regenerative treatment options among both patients and healthcare providers
- North America dominated the cartilage regeneration market with the largest revenue share of 41.8% in 2024, supported by a robust healthcare infrastructure, rising geriatric population, and growing investments in regenerative medicine research, with the U.S. at the forefront due to the presence of leading biotech firms, clinical trials, and high adoption of advanced therapies
- Asia-Pacific is expected to be the fastest growing region in the cartilage regeneration market during the forecast period, fueled by improving healthcare access, rising medical tourism, and increasing government support for advanced therapies
- The cell-based segment dominated the cartilage regeneration market with a market share of 48.3% in 2024, attributed to its effectiveness in restoring damaged cartilage using autologous or allogeneic cell therapies, which are gaining traction for long-term clinical outcomes
